Search results
Author(s):
Eirik Ikdahl
,
Anne Kerola
,
Eli Sollerud
,
et al
Added:
4 months ago
Author(s):
Martin Berger
,
Nikolaus Marx
,
Katharina Marx-Schütt
Added:
1 month ago
Author(s):
Massimiliano Camilli
,
Luca Maggio
,
Lorenzo Tinti
,
et al
Added:
1 month ago
Author(s):
Deepak L Bhatt
Added:
2 months ago
In this insightful interview, Dr Deepak Bhatt (Mount Sinai Hospital, US) joins us to discuss findings from a post-hoc analysis of the REDUCE-IT trial, examining how icosapent ethyl affects cardiovascular outcomes across different baseline LDL-C levels.The study included 8,175 statin-treated patients with elevated cardiovascular risk and triglyceride levels between 135-499mg/dL. All participants…
View more
Author(s):
Michael Lichtenberg
Added:
3 months ago
LINC 2025 - 36-month outcomes of the Aspirex endovascular thrombectomy system for patients with acute iliofemoral deep vein thrombosis (DVT) show great efficacy with low rates of major adverse events, perioperative death, and complication.Dr Michael Lichtenberg (Vascular Centre Clinic Arnsberg, Arnsberg, DE) joins us to discuss the findings from the multi-centre, post-market, follow-up study in…
View more
Conduction System Pacing: A Fresh Look
Author(s):
Óscar Cano
,
Marek Jastrzębski
,
Pugazhendhi Vijayaraman
Start date:
Nov 13, 2024
Broadcast
Author(s):
Yimeng Zhang
,
Nimai Desai
,
Derek Connolly
Added:
2 months ago
Author(s):
Josef Kautzner
,
Petr Peichl
,
Rune Paamand
,
et al
Added:
1 year ago
Author(s):
D Scott Lim
Added:
2 years ago
EuroPCR 23 - Dr Scott Lim (UVA Health Heart and Vascular Center, US) joins us to discuss the findings of the DRAGONFLY-DMR trial. (NCT04734756)
The purpose of the study was to assess the effectiveness and safety of the Dragonfly transcatheter mitral valve repair system (Hangzhou Valgen Medtech) for treating symptomatic moderate-to-severe (3+) or severe (4+) degenerative mitral regurgitation (DMR…
View more
Author(s):
Michael C Gibson
,
Dipti Itchhaporia
Added:
7 months ago
In this episode of the "Innovations in Cardiology" series, host Dr Dipti Itchhaporia, former president of the ACC, is joined by Dr C. Michael Gibson, CEO of the Baim Institute for Research, for an insightful discussion on the latest advancements and future directions in cardiovascular innovation for 2024.Dr Itchhaporia and Dr Gibson explore strategies to enhance efficiency in cardiovascular…
View more